1	Enviar	enviar	VMN0000	-	-	0-6	495_ANS_clinical_caseMIR	SENT1	-	-
2	al	al	SP+DA	-	-	7-9	495_ANS_clinical_caseMIR	SENT1	-	-
3	hospital	hospital	NCMS000	C1510665	medio_ambiente	10-18	495_ANS_clinical_caseMIR	SENT1	-	-
4	para	para	SPS00	C0521125	calificador	19-23	495_ANS_clinical_caseMIR	SENT1	-	-
5	vacunar	vacunar	VMN0000	-	-	24-31	495_ANS_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0332285	atributo	32-34	495_ANS_clinical_caseMIR	SENT1	-	-
7	rabia	rabia	NCFS000	C0034494	trastorno	35-40	495_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
8	y	y	CC	C1706368	calificador	41-42	495_ANS_clinical_caseMIR	SENT1	-	-
9	tétanos	tétanos	NCMS000	C0039614#C0343495	trastorno	43-50	495_ANS_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
10	y	y	CC	C1706368	calificador	51-52	495_ANS_clinical_caseMIR	SENT1	-	-
11	mantener	mantener	VMN0000	-	-	53-61	495_ANS_clinical_caseMIR	SENT1	-	-
12	en	en	SPS00	C1720294#C0332285	calificador#atributo	62-64	495_ANS_clinical_caseMIR	SENT1	-	-
13	observación	observación	NCFS000	C0557985	procedimiento	65-76	495_ANS_clinical_caseMIR	SENT1	-	-
14	.	.	Fp	-	-	76-77	495_ANS_clinical_caseMIR	SENT1	-	-

1	Limpiar	limpiar	VMN0000	-	-	0-7	495_ANS_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	8-10	495_ANS_clinical_caseMIR	SENT2	-	-
3	herida	herido	NCFS000	-	-	11-17	495_ANS_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
4	y	y	CC	C1706368	calificador	18-19	495_ANS_clinical_caseMIR	SENT2	-	-
5	administrar	administrar	VMN0000	C1621583	calificador	20-31	495_ANS_clinical_caseMIR	SENT2	-	-
6	gammaglobulina	gammaglobulina	NCFS000	C0017007	sustancia	32-46	495_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
7	inespecífica	inespecífico	AQ0FS0	C0205370	calificador	47-59	495_ANS_clinical_caseMIR	SENT2	-	-
8	intramuscular	intramuscular	AQ0CS0	C0442117	calificador	60-73	495_ANS_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
9	.	.	Fp	-	-	73-74	495_ANS_clinical_caseMIR	SENT2	-	-

1	Dar	dar	VMN0000	C1947971	calificador	0-3	495_ANS_clinical_caseMIR	SENT3	-	-
2	400	400	Z	-	-	4-7	495_ANS_clinical_caseMIR	SENT3	-	-
3	mg	mg	NCMN000	-	-	8-10	495_ANS_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	11-13	495_ANS_clinical_caseMIR	SENT3	-	-
5	moxifloxacino	moxifloxacino	NC00SC0	C0536495	producto#sustancia	14-27	495_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
6	oral	oral	AQ0CS0	C0442027	calificador	28-32	495_ANS_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
7	y	y	CC	C1706368	calificador	33-34	495_ANS_clinical_caseMIR	SENT3	-	-
8	enviar	enviar	VMN0000	-	-	35-41	495_ANS_clinical_caseMIR	SENT3	-	-
9	al	al	SP+DA	-	-	42-44	495_ANS_clinical_caseMIR	SENT3	-	-
10	hospital	hospital	NCMS000	C1510665	medio_ambiente	45-53	495_ANS_clinical_caseMIR	SENT3	-	-
11	.	.	Fp	-	-	53-54	495_ANS_clinical_caseMIR	SENT3	-	-

1	Dar	dar	VMN0000	C1947971	calificador	0-3	495_ANS_clinical_caseMIR	SENT4	-	-
2	clindamicina	clindamicina	NC00SC0	C0008947	sustancia	4-16	495_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
3	600	600	Z	-	-	17-20	495_ANS_clinical_caseMIR	SENT4	-	-
4	mg	mg	NCMN000	-	-	21-23	495_ANS_clinical_caseMIR	SENT4	-	-
5	oral	oral	AQ0CS0	C0442027	calificador	24-28	495_ANS_clinical_caseMIR	SENT4	-	-
6	cada	cada	DI0CS0	C1457900	calificador	29-33	495_ANS_clinical_caseMIR	SENT4	-	-
7	8	8	Z	C1292429_1	calificador_1	34-35	495_ANS_clinical_caseMIR	SENT4	-	-
8	horas	hora	NCFP000	C1292429_2	calificador_2	36-41	495_ANS_clinical_caseMIR	SENT4	-	-
9	y	y	CC	C1706368	calificador	42-43	495_ANS_clinical_caseMIR	SENT4	-	-
10	observación	observación	NCFS000	C0557985	procedimiento	44-55	495_ANS_clinical_caseMIR	SENT4	-	-
11	.	.	Fp	-	-	55-56	495_ANS_clinical_caseMIR	SENT4	-	-

